The 16th Annual Survey on Consumer Awareness of Drugs and the Pharmaceutical Industry

The Japan Pharmaceutical Manufacturers Association (JPMA) is pleased to announce that the results of the "16th Survey on Consumer Awareness of Drugs and the Pharmaceutical Industry" conducted this year are now available on the JPMA website.

 

 

The 16th Survey on Sei-katsu-sha Awareness of Drugs and the Pharmaceutical Industry

 

According to the results of this year's survey, the level of trust in the pharmaceutical industry was 88%, indicating that the level of trust is as high as ever. In terms of the image of the pharmaceutical industry, positive responses such as "an industry that is highly necessary to society" and "an industry with strong technological capabilities" were the most common responses. In addition, the survey also showed a high level of opinions regarding new drug development, with respondents stating that "new drug development is necessary" and "socially meaningful," indicating that the pharmaceutical industry and its activities are highly valued and expected by consumers and patients.

In addition, a new question this year asked respondents about changes in their attitudes toward health, medicine, and medical care before and after the coronary disaster. 39% of respondents answered that their attitudes had "changed" or "changed somewhat," and 67% of them answered that their health awareness had "increased.

 

With new coronavirus infections still affecting social life around the world, the mission of the pharmaceutical industry is more recognized than ever. In order to meet the expectations of our stakeholders and continue to earn their strong trust even in a changing social climate, we will continue to promote the activities of the Pharmaceutical Manufacturers Association of Japan (PMAJ) by making maximum use of the results of this survey.